116 related articles for article (PubMed ID: 11409489)
1. In-vitro test system for the evaluation of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibitors based on a single HPLC run with UV detection using bovine aortic coronary endothelial cells (BAECs).
Dannhardt G; Ulbrich H
Inflamm Res; 2001 May; 50(5):262-9. PubMed ID: 11409489
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
3. Development of an in-vitro test system for the evaluation of cyclooxygenase-2 inhibitors.
Laufer S; Zechmeister P; Klein T
Inflamm Res; 1999 Mar; 48(3):133-8. PubMed ID: 10219655
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.
Henrotin Y; de Leval X; Mathy-Hartet M; Mouithys-Mickalad A; Deby-Dupont G; Dogné JM; Delarge J; Reginster JY
Inflamm Res; 2001 Aug; 50(8):391-9. PubMed ID: 11556519
[TBL] [Abstract][Full Text] [Related]
5. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes.
Blanco FJ; Guitian R; Moreno J; de Toro FJ; Galdo F
J Rheumatol; 1999 Jun; 26(6):1366-73. PubMed ID: 10381057
[TBL] [Abstract][Full Text] [Related]
6. Duplexes of 21 nucleotide RNA specific for COX II mediates RNA interference in cultured bovine aortic coronary endothelial cells (BAECs).
Xiuzhu T; Shore L; Stram Y; Michaeli SC; Brietbart HC; Shemesh M
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):119-29. PubMed ID: 14518556
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
[TBL] [Abstract][Full Text] [Related]
8. Kinetic basis for selective inhibition of cyclo-oxygenases.
Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
[TBL] [Abstract][Full Text] [Related]
9. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.
Riendeau D; Percival MD; Brideau C; Charleson S; Dubé D; Ethier D; Falgueyret JP; Friesen RW; Gordon R; Greig G; Guay J; Mancini J; Ouellet M; Wong E; Xu L; Boyce S; Visco D; Girard Y; Prasit P; Zamboni R; Rodger IW; Gresser M; Ford-Hutchinson AW; Young RN; Chan CC
J Pharmacol Exp Ther; 2001 Feb; 296(2):558-66. PubMed ID: 11160644
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
11. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
[TBL] [Abstract][Full Text] [Related]
13. Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac.
Hinz B; Rau T; Auge D; Werner U; Ramer R; Rietbrock S; Brune K
Clin Pharmacol Ther; 2003 Sep; 74(3):222-35. PubMed ID: 12966366
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cell growth by selective COX-2 inhibitors in oral carcinoma cell lines.
Yang CY; Meng CL; Liao CL; Wong PY
Prostaglandins Other Lipid Mediat; 2003 Nov; 72(3-4):115-30. PubMed ID: 14674624
[TBL] [Abstract][Full Text] [Related]
15. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory activity of tryptanthrin on prostaglandin and leukotriene synthesis.
Danz H; Stoyanova S; Thomet OA; Simon HU; Dannhardt G; Ulbrich H; Hamburger M
Planta Med; 2002 Oct; 68(10):875-80. PubMed ID: 12391548
[TBL] [Abstract][Full Text] [Related]
17. Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase.
Cheng MK; McGiff JC; Carroll MA
Am J Physiol Renal Physiol; 2003 Mar; 284(3):F474-9. PubMed ID: 12419775
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes.
Kato M; Nishida S; Kitasato H; Sakata N; Kawai S
J Pharm Pharmacol; 2001 Dec; 53(12):1679-85. PubMed ID: 11804398
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of COX in ocular tissues: an in vitro model to identify selective COX-2 inhibitors.
García-Cabanes C; Palmero M; Bellot JL; Castillo M; Orts A
J Ocul Pharmacol Ther; 2001 Feb; 17(1):67-74. PubMed ID: 11322639
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
Mitchell JA; Akarasereenont P; Thiemermann C; Flower RJ; Vane JR
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11693-7. PubMed ID: 8265610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
